KR20220103812A - 태반 줄기 세포를 이용하는 척수 손상 및 외상성 뇌 손상의 치료 - Google Patents

태반 줄기 세포를 이용하는 척수 손상 및 외상성 뇌 손상의 치료 Download PDF

Info

Publication number
KR20220103812A
KR20220103812A KR1020227023531A KR20227023531A KR20220103812A KR 20220103812 A KR20220103812 A KR 20220103812A KR 1020227023531 A KR1020227023531 A KR 1020227023531A KR 20227023531 A KR20227023531 A KR 20227023531A KR 20220103812 A KR20220103812 A KR 20220103812A
Authority
KR
South Korea
Prior art keywords
cells
placental
isolated
population
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020227023531A
Other languages
English (en)
Korean (ko)
Inventor
스튜어트 애보트
제임스 더블유. 에딩거
알렉잔다르 프란키
블라디미르 얀코비치
알렉산드르 카플루노브스키
크리스텐 라바쪼
에릭 로우
비타오 리앙
로버트 제이. 하리리
Original Assignee
셀룰래리티 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 셀룰래리티 인코포레이티드 filed Critical 셀룰래리티 인코포레이티드
Priority to KR1020237025647A priority Critical patent/KR20230116964A/ko
Publication of KR20220103812A publication Critical patent/KR20220103812A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Virology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Transplantation (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
KR1020227023531A 2010-12-17 2011-12-15 태반 줄기 세포를 이용하는 척수 손상 및 외상성 뇌 손상의 치료 Ceased KR20220103812A (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020237025647A KR20230116964A (ko) 2010-12-17 2011-12-15 태반 줄기 세포를 이용하는 척수 손상 및 외상성 뇌손상의 치료

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201061424559P 2010-12-17 2010-12-17
US61/424,559 2010-12-17
PCT/US2011/065170 WO2012083024A1 (en) 2010-12-17 2011-12-15 Treatment of spinal cord injury and traumatic brain injury using placental stem cells
KR1020217026195A KR20210107144A (ko) 2010-12-17 2011-12-15 태반 줄기 세포를 이용하는 척수 손상 및 외상성 뇌 손상의 치료

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020217026195A Division KR20210107144A (ko) 2010-12-17 2011-12-15 태반 줄기 세포를 이용하는 척수 손상 및 외상성 뇌 손상의 치료

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020237025647A Division KR20230116964A (ko) 2010-12-17 2011-12-15 태반 줄기 세포를 이용하는 척수 손상 및 외상성 뇌손상의 치료

Publications (1)

Publication Number Publication Date
KR20220103812A true KR20220103812A (ko) 2022-07-22

Family

ID=46234728

Family Applications (7)

Application Number Title Priority Date Filing Date
KR1020227023531A Ceased KR20220103812A (ko) 2010-12-17 2011-12-15 태반 줄기 세포를 이용하는 척수 손상 및 외상성 뇌 손상의 치료
KR1020137018583A Ceased KR20130128437A (ko) 2010-12-17 2011-12-15 태반 줄기 세포를 이용하는 척수 손상 및 외상성 뇌 손상의 치료
KR1020197021890A Ceased KR20190090882A (ko) 2010-12-17 2011-12-15 태반 줄기 세포를 이용하는 척수 손상 및 외상성 뇌 손상의 치료
KR1020207027962A Ceased KR20200116546A (ko) 2010-12-17 2011-12-15 태반 줄기 세포를 이용하는 척수 손상 및 외상성 뇌 손상의 치료
KR1020237025647A Ceased KR20230116964A (ko) 2010-12-17 2011-12-15 태반 줄기 세포를 이용하는 척수 손상 및 외상성 뇌손상의 치료
KR1020187024573A Ceased KR20180100251A (ko) 2010-12-17 2011-12-15 태반 줄기 세포를 이용하는 척수 손상 및 외상성 뇌 손상의 치료
KR1020217026195A Ceased KR20210107144A (ko) 2010-12-17 2011-12-15 태반 줄기 세포를 이용하는 척수 손상 및 외상성 뇌 손상의 치료

Family Applications After (6)

Application Number Title Priority Date Filing Date
KR1020137018583A Ceased KR20130128437A (ko) 2010-12-17 2011-12-15 태반 줄기 세포를 이용하는 척수 손상 및 외상성 뇌 손상의 치료
KR1020197021890A Ceased KR20190090882A (ko) 2010-12-17 2011-12-15 태반 줄기 세포를 이용하는 척수 손상 및 외상성 뇌 손상의 치료
KR1020207027962A Ceased KR20200116546A (ko) 2010-12-17 2011-12-15 태반 줄기 세포를 이용하는 척수 손상 및 외상성 뇌 손상의 치료
KR1020237025647A Ceased KR20230116964A (ko) 2010-12-17 2011-12-15 태반 줄기 세포를 이용하는 척수 손상 및 외상성 뇌손상의 치료
KR1020187024573A Ceased KR20180100251A (ko) 2010-12-17 2011-12-15 태반 줄기 세포를 이용하는 척수 손상 및 외상성 뇌 손상의 치료
KR1020217026195A Ceased KR20210107144A (ko) 2010-12-17 2011-12-15 태반 줄기 세포를 이용하는 척수 손상 및 외상성 뇌 손상의 치료

Country Status (9)

Country Link
US (1) US20120156230A1 (https=)
EP (1) EP2651451A4 (https=)
JP (1) JP2014507390A (https=)
KR (7) KR20220103812A (https=)
CN (1) CN103501822A (https=)
AU (1) AU2011343739A1 (https=)
CA (1) CA2821818A1 (https=)
MX (1) MX2013006595A (https=)
WO (1) WO2012083024A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2666503T3 (es) * 2012-05-16 2018-05-04 Becton, Dickinson And Company Características distintivas de superficie celular para aislar neuronas de cultivos celulares derivados de células madre pluripotentes
JP2015521630A (ja) * 2012-06-26 2015-07-30 ラスティー プロパティー ホールディングス プロプライエタリー リミテッド 頭痛の頻度および／または重症度を下げるための組成物および方法
WO2014022427A1 (en) * 2012-08-02 2014-02-06 Bioaxone Biosciences Inc. Inhibition of rho and or rock and cell transplantation
US20160120909A1 (en) * 2013-05-10 2016-05-05 Cell-Innovations Ip Pty Ltd Compositions And Methods For The Treatment Of Tinnitus
WO2015023901A1 (en) * 2013-08-15 2015-02-19 The Regents Of The University Of California Placenta-derived multipotent stem cells
JP7109160B2 (ja) 2014-06-18 2022-07-29 ツェー・エス・エル・ベーリング・ゲー・エム・ベー・ハー 神経外傷性障害において第ｘｉｉ因子インヒビターを使用する療法
US10493105B2 (en) * 2014-09-11 2019-12-03 Taiwan Mitochondrion Applied Technology Co., Ltd Isolated adipose-derived mesenchymal stem cells treated with angelica extract or butylidenephthalide, and wherein the cells have an increased mitochondrial membrane potential and a decreased level of IL-8, and methods for treating parkinson's disease
GB201518263D0 (en) * 2015-10-15 2015-12-02 Oxford Bioelectronics Ltd Method
WO2017152035A1 (en) * 2016-03-03 2017-09-08 Henry Ford Health System 3-d collagen scaffold-generated exosomes and uses thereof
CA3046078A1 (en) * 2016-12-05 2018-06-14 Celularity Inc. Treatment of lymphedema and related conditions using placental adherent cells
US20200246386A1 (en) * 2017-04-24 2020-08-06 Pluristem Ltd. Methods and compositions for treating neurological disorders
US20180322956A1 (en) * 2017-05-05 2018-11-08 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Time Window-Based Platform for the Rapid Stratification of Blunt Trauma Patients into Distinct Outcome Cohorts
EP3630963A1 (en) 2017-05-30 2020-04-08 BioAxone BioSciences, Inc. C3 fusion protein and methods of making and using thereof
CN107227521B (zh) * 2017-08-09 2023-03-14 青岛金汇丰机械有限公司 一种五轴毛纺粗纱机
KR20190048894A (ko) 2017-10-31 2019-05-09 경상대학교산학협력단 Jnk 활성 억제제를 유효성분으로 포함하는 퇴행성 신경질환의 예방 또는 치료용 약학적 조성물
CN108413478A (zh) * 2018-02-11 2018-08-17 广东美的环境电器制造有限公司 一种控制方法、装置及计算机可读存储介质
KR102070403B1 (ko) 2019-09-06 2020-01-28 경상대학교 산학협력단 Jnk 활성 억제제를 유효성분으로 포함하는 외상성 뇌손상의 치료용 약학적 조성물
CN114561355B (zh) * 2022-01-23 2023-04-11 四川大学华西医院 一种脊髓瘢痕组织细胞急性快速分离方法
CN117274869B (zh) * 2023-09-25 2024-03-26 北方工业大学 一种基于形变场提取的细胞形变动态分类方法及系统

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7311905B2 (en) * 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
US20080152629A1 (en) * 2000-12-06 2008-06-26 James Edinger Placental stem cell populations
PT2471904T (pt) * 2005-12-29 2019-02-25 Celularity Inc População de células estaminais placentárias
WO2008036374A2 (en) * 2006-09-21 2008-03-27 Medistem Laboratories, Inc. Allogeneic stem cell transplants in non-conditioned recipients
EP3763376A1 (en) * 2007-02-12 2021-01-13 Celularity, Inc. Treatment of inflammatory diseases using placental stem cells
US20090214484A1 (en) * 2008-02-22 2009-08-27 Nikolay Mironov Stem cell therapy for the treatment of central nervous system disorders
WO2010021715A1 (en) * 2008-08-20 2010-02-25 Anthrogenesis Corporation Treatment of stroke using isolated placental cells
AU2009316541B2 (en) * 2008-11-19 2015-08-06 Celularity Inc. Amnion derived adherent cells

Also Published As

Publication number Publication date
KR20130128437A (ko) 2013-11-26
US20120156230A1 (en) 2012-06-21
KR20210107144A (ko) 2021-08-31
WO2012083024A1 (en) 2012-06-21
EP2651451A4 (en) 2014-05-21
AU2011343739A1 (en) 2013-05-02
KR20180100251A (ko) 2018-09-07
WO2012083024A8 (en) 2013-08-01
KR20200116546A (ko) 2020-10-12
MX2013006595A (es) 2014-04-07
KR20190090882A (ko) 2019-08-02
CN103501822A (zh) 2014-01-08
EP2651451A1 (en) 2013-10-23
JP2014507390A (ja) 2014-03-27
KR20230116964A (ko) 2023-08-04
CA2821818A1 (en) 2012-06-21

Similar Documents

Publication Publication Date Title
KR20220103812A (ko) 태반 줄기 세포를 이용하는 척수 손상 및 외상성 뇌 손상의 치료
US11090339B2 (en) Treatment of pain using placental stem cells
US8071376B2 (en) Production of oligodendrocytes from placenta-derived stem cells
KR101993254B1 (ko) 태반 줄기 세포를 사용한 혈관신생
US20120201787A1 (en) Treatment of spinal cord injury and traumatic brain injury using amnion derived adherent cells
KR20180100250A (ko) 양막 유래 부착성 세포를 사용한, 면역-관련 질환 및 장애의 치료
US20230302058A1 (en) Treatment of lymphedema and related conditions using placental adherent cells
HK1162600A (en) Production of oligodendrocytes from placenta-derived stem cells

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20220708

Application number text: 1020217026195

Filing date: 20210818

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20220805

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20220811

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20230225

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20220811

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20230726

Application number text: 1020217026195

Filing date: 20210818